Article
Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses.
PloS one - 1 Jan 2013
Guo Xiaoyan, Yang Guilin, Yuan Jin, Ruan Peng, Zhang Mingxia, Chen Xincun, Zhou Boping
Abstract excerpt
Concurrent infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) was not uncommon in China. To date, information on predictors of response to treatment of dually-infected HCV/HBV is limited. The aim of this study was to evaluated whether determination of the interleukin 28B (IL-28B) polymorphism statuses sufficient to predict treatment response of interferon (IFN)-based therapy in patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
